IMM Health Care Sector News

Immutep Ltd

About IMM

Immutep (IMM) is a Phase III biotech developing LAG-3-related immunotherapies for cancer and autoimmune disease.

All News for IMM

No news articles found for IMM yet.

ASX Code IMM

Sector Health Care Sector News

Total Articles 0

Latest News N/A